APH-1 is one of four components of the secretase activity responsible for the final intramembrane cleavage of Notch Receptor, -amyloid precursor protein, and a growing list of other substrates. In C. elegans, the
aph-1 gene was identified based on its Notch-like mutant phenotype that leads to maternal-effect embryonic lethality. Reduction of
aph-1 activity can also cause post-embryonic Notch-type phenotypes such as defects in germline proliferation and defects in vulval development. For example, the recessive
aph-1(
or28) mutation causes a fully penetrant egg laying defect which we have characterized as a failure in uterine pie cell induction, similar to that shown for
sel-12 mutants,
aph-2 mutants, and partial loss-of-function
lin-12 mutants. The miss-specification of pie cells leads to a physical block between the uterine and vulval tissues in
aph-1(
or28) animals. In contrast, these animals are not defective in the AC-VU decision that is also mediated by the Notch receptor LIN-12. In order to better follow the role of APH-1 during vulval development we have characterized the expression pattern of an
aph-1::gfp fusion construct, and found expression in neurons near the vulval region. The expression pattern does not correlate with a role for APH-1 in the well characterized events of AC-VU interaction or pie cell induction, but rather suggests yet another situation in which
aph-1 activity may be involved. Thus far we have been unable to detect defects in neurons or neuronal components in
aph-1 mutant worms, so we have turned to analyzing neuronal function by assaying the ability of
aph-1 mutants to lay eggs in response to drug stimulation (for these studies we have used
aph-1 mutants that do not cause physical blocks to egg laying, as well as
aph-1 RNAi). Our progress on these analyses will be presented.